article thumbnail

Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development

The Pharma Data

Kazumi is a biotech veteran with an outstanding track record in corporate development and fundraising across both European and US markets, while Lisa brings extensive experience in drug discovery and development from roles at Magenta Therapeutics, AbbVie and Pfizer. Kazumi holds a PhD in Synthetic Chemistry from UC Berkeley.

article thumbnail

BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

The Pharma Data

These include in-vitro assays, cell-based phenotypic assays, safety pharmacology and efficacy, ADME toxicology, medicinal chemistry design, synthetic chemistry, and custom proteins and assay development capabilities. Cautionary Note Regarding Forward-Looking Statements.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ProstaStream

The Pharma Data

The Journal of Synthetic Chemistry confirms that broccoli leaf extracts have extremely powerful and valuable nutrients, ones that are required to maintain the good health of the prostate. Frank Neal is a pen name used for marketing purposes and to protect the author’s identity.

article thumbnail

AWS helps Pfizer accelerate drug development and clinical manufacturing

The Pharma Data

. “Pfizer’s goal with AWS is to expedite the processes for drug discovery and development in ways that can ultimately enhance patient experiences and deliver new therapies to market. Pfizer has an extensive collection of documents that contain valuable data from a variety of drug development processes.